Furthermore, reduced farnesoid x receptor (FXR) signaling is thought to induce activation of the macrophage inflammasome in cholestasis and endotoxemia, thereby promoting IL-1β release and increasing immune susceptibility in cholestasis [13]. Here, IL1B is linked to cholestasis.